Cancer immunotherapy treatments harness the power of a patient’s own immune system to recognize and destroy cancer cells.
SITC Cancer Immunotherapy CONNECT is your hub to learn about cancer immunotherapy and its potential for the future. Download a variety of resources in our library and connect to other patients and healthcare professionals in our online community to learn more about this powerful new treatment option for cancer.
The use of this treatment dates back to the late 1800s; however, the science has never before experienced such positive momentum in improving the lives of patients with cancer as in recent years. As more immunotherapy treatments receive U.S. Food and Drug Administration (FDA) approval for a variety of cancer types, stay connected with SITC for up-to-date resources and education about immunotherapy for cancer treatment.
It was great seeing old friends again and meeting new ones at the 32 nd Annual Meeting & Pre-Conference Programs in National Harbor! We appreciate all who joined SITC for our most successful ...
The cited 2017 case report states " The restoration of the cellular immune response against tumor cells through PD-1 blockade and CRLA-4 blockade have recently been shown to be associated ...
This is an interesting subject to me since a few years back we published a study in the American Journal of Transplantation that showed blocking mTOR with a low dose of rapamycin enhanced ...
Thanks for the comments. He is to start TKI, but is also asking about other ideas. There are multiple non-Oncologist physicians in family who are feeding him questions and idea. I'm sure ...
View More Patient Resources
Either the content you're seeking doesn't exist or it requires proper authentication before viewing.
Launched in July of 2016, SITC presents the newest in a series of videos focusing on immunotherapy for NSCLC patients, the NSCLC Immunotherapy: Advancing HopeTM video provides an overview of the building blocks of the immune system and immunotherapy, while also highlighting some* of the available FDA approved immunotherapy treatments and potential side effects, and the importance of clinical trials.
For more than 30 years SITC (Society for Immunotherapy of Cancer) has been fighting for treatment and a cure for cancer through research and collaboration. SITC members all over the world are leading the charge against cancer. We’re traveling the globe to meet these thought leaders and demonstrate the crucial work that they’re doing to impact advances in both the science and clinical application of immunotherapy.
Tel: +1 414 271 2456 | Fax: +1 414 276 3349 | Email: email@example.com